Complete FDA and NHTSA recall records dated in April 2023.
These records include useful source details for the selected month.
Lithium-ion batteries in glucose monitoring system readers may swell, overheat, or pose fire hazard. Only use the charging cable/power adapter included with readers. Do not use reader if it…
Potential for packaging non-conformances directly related to the dual-barrier, sterile pouch packaging system. Non-conforming packaging may lead to a breach in the sterile barrier.
Not able to achieve desired pressure and not holding pressure result from two different causes which have been reported to occur during initial set-up of the cuff onto the patient, may lead…
During internal testing, Regulatory Compliance issues were identified regarding the Monitor and Power Supplies for fluid ingress and basic safety issues.
Some Capiox NX, RX and FX Oxygenators may contain an arterial thermistor component that is improperly bonded to the oxygenator port. This may result in a leak at the point where the…
Possible contamination with Listeria monocytogenes
Cashews declared in ingredients statement but not in the contains statement.
Product was found to have the incorrect crustacean named on products
The firm was notified by a customer that the outer case label indicates the product contains eggs. However, the primary product label does not include egg in the ingredient list.
Product was found to have the incorrect crustacean named on products
Infant Formula has the potential to be contaminated with Cronobacter spp.
cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.
CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
cGMP Deviations
CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.
Sub-potent drug: assay test result below specifications at 9-month timepoint.
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Failed Impurities/Degradation Specifications: failed impurities for Sulphoxide and Impurity A.
CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.
BMW of North America, LLC (BMW) is recalling certain 2023 X1 xDrive28i, X1 M35i vehicles. On the second-row outboard seats, the seat belts may have been pinched by an interior trim panel…
Subaru of America, Inc. (Subaru) is recalling certain 2023 Ascent vehicles equipped with 20-inch wheels. The internal tire bead may have been damaged during the wheel mounting process.
BMW of North America, LLC (BMW) is recalling certain 2023 X5 sDrive40i, X5 xDrive40i, X5 M50i, X5 M and X5 xDrive45e vehicles. The head restraints for the second-row outboard seats may have…
Use this page to compare the recalls reported during the month, then open an individual record for the exact reason, classification, company, remedy or distribution information available from the official source. Monthly counts are descriptive, not a safety rating.
